CD19 and leukemia: Importantly, while all the residual leukemia cells expressed dsRed, they were CD19–CD133– (supplemental Figure 2F), suggesting complete elimination of target cells coexpressing CD19 and CD133 even when expressed at low levels, and in line with the higher avidity of bispecific CAR-iNKT cells.